Product Reports Resources Pricing Login Book a demo

Scholar Rock

Biotech & Life Sciences · Cambridge, United States · Founded 2012 · IPO 2018

Clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a… MoreLess

Scholar Rock is a biopharmaceutical company focused on developing innovative treatments for diseases by targeting protein growth factors. Operating in the healthcare and biotechnology market, Scholar Rock serves patients and healthcare providers by offering novel therapeutic solutions. The company leverages its unique drug discovery platform to unlock new possibilities in disease treatment, particularly in areas that have been historically overlooked. Scholar Rock's business model revolves around research and development, partnerships, and collaborations with other biopharmaceutical companies and institutions. Revenue is generated through licensing agreements, milestone payments, and eventual product sales. The company is committed to patient-centric approaches and values scientific curiosity and collaboration.

Keywords: biopharmaceutical, protein growth factors, innovative treatments, drug discovery, healthcare, biotechnology, patient-centric, research and development, partnerships, collaborations.

Valuation $6.03B
Revenue $5.8M
Total funding $100–500M

Talent graph

Scholar Rock's talent

Book a demo to see the people
Team profiled 20 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 6 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

11 investors on Scholar Rock's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 4 investors entered at this stage
ARCH Venture Partners
The Kraft Group
EcoR1 Capital
Fidelity Investments
Series B+ 6 investors entered at this stage
Invus
Silicon Valley Bank
Oxford Finance
Samsara BioCapital
Redmile Group
Blue Owl Capital

Global footprint

Where Scholar Rock has talent and traffic

Workforce by country
7 countries with
team presence
🇺🇸 United States96.3%
🇮🇪 Ireland1.1%
🇨🇭 Switzerland0.7%
🇬🇧 United Kingdom0.7%
🇩🇪 Germany0.4%
Top 5 of 7 shown

Market sentiment

What the market is saying about Scholar Rock

An AI-synthesized read of the highest-engagement posts about Scholar Rock on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Scholar Rock on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.